Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Washington University
mi
from
St. Louis, MO
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Montefiore Medical Center
mi
from
Bronx, NY
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Updated: 1/1/1970
Montefiore Medical Center
mi
from
Bronx, NY
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
FirstHealth Moore Regional Hospital
mi
from
Pinehurst, NC
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Updated: 1/1/1970
FirstHealth Moore Regional Hospital
mi
from
Pinehurst, NC
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
New Hanover Regional Hospital
mi
from
Wilmington, NC
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Updated: 1/1/1970
New Hanover Regional Hospital
mi
from
Wilmington, NC
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Eastern Va Medical School
mi
from
Norfolk, VA
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia
Status: Archived
Updated: 1/1/1970
Eastern Va Medical School
mi
from
Norfolk, VA
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Children's Medical Center of Dallas
mi
from
Dallas, TX
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Updated: 1/1/1970
Children's Medical Center of Dallas
mi
from
Dallas, TX
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
University of Florida Gainesville
mi
from
Gainesville, FL
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
mi
from
Gainesville, FL
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Children's Hospital - Boston
mi
from
Boston, MA
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Updated: 1/1/1970
Children's Hospital - Boston
mi
from
Boston, MA
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Saint Vincent Healthcare Pediatric Specialty Clinics
mi
from
Billings, MT
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Updated: 1/1/1970
Saint Vincent Healthcare Pediatric Specialty Clinics
mi
from
Billings, MT
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
Status: Archived
Updated: 1/1/1970
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure
A Prospective, Multi-Center Investigation Of The Safety And Performance Of The Covidien EEAâ„¢ Hemorrhoid And Prolapse Stapling Set With DST Seriesâ„¢ Technology Im A Hemorrhoidopexy Procedure
Status: Archived
Weill Medical College of Cornell University
mi
from
New York, NY
Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure
A Prospective, Multi-Center Investigation Of The Safety And Performance Of The Covidien EEAâ„¢ Hemorrhoid And Prolapse Stapling Set With DST Seriesâ„¢ Technology Im A Hemorrhoidopexy Procedure
Status: Archived
Updated: 1/1/1970
Weill Medical College of Cornell University
mi
from
New York, NY
Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
Status: Archived
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
Status: Archived
Updated: 1/1/1970
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Effect of Bispectral Index (BIS) Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients
Effect of BIS Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients
Status: Archived
Cleveland Clinic Florida
mi
from
Weston, FL
Effect of Bispectral Index (BIS) Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients
Effect of BIS Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
Idiopathic Gastroparesis Registry to Define Severity, Treatment Response, and Prognosis Using a Predominant-Symptom Classification
Status: Archived
University of Louisville Hospital
mi
from
Louisville, KY
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
Idiopathic Gastroparesis Registry to Define Severity, Treatment Response, and Prognosis Using a Predominant-Symptom Classification
Status: Archived
Updated: 1/1/1970
University of Louisville Hospital
mi
from
Louisville, KY
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Little Rock, AR
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Little Rock, AR
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Newington, CT
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Newington, CT
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Atlanta, GA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Atlanta, GA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Metairie, LA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Metairie, LA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Detroit, MI
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Detroit, MI
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
St Louis, MO
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
St Louis, MO
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Albuquerque, NM
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albuquerque, NM
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Charlotte, NC
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Ogden, UT
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Ogden, UT
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Clinical Trial Facility
mi
from
Richmond, VA
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Richmond, VA
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Alabama Digestive Disorders Center
mi
from
Huntsville, AL
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
Alabama Digestive Disorders Center
mi
from
Huntsville, AL
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Research Associates of New York
mi
from
, NY
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
Research Associates of New York
mi
from
, NY
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
University of North Carolina Division of Digestive Disease
mi
from
Chapel Hill,, NC
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
University of North Carolina Division of Digestive Disease
mi
from
Chapel Hill,, NC
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Digestive Care, Inc.
mi
from
Beavercreek, OH
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
Digestive Care, Inc.
mi
from
Beavercreek, OH
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Franklin Gastroenterology
mi
from
Franklin, TN
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
Franklin Gastroenterology
mi
from
Franklin, TN
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
Status: Archived
Updated: 1/1/1970
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function
An Open-Label Study to Evaluate the Pharmacokinetics of a Single Oral Dose of 300 mg JNJ-28431754 (Canagliflozin) in Subjects With Various Degrees of Impaired Hepatic Function Compared With Subjects With Normal Hepatic Function
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function
An Open-Label Study to Evaluate the Pharmacokinetics of a Single Oral Dose of 300 mg JNJ-28431754 (Canagliflozin) in Subjects With Various Degrees of Impaired Hepatic Function Compared With Subjects With Normal Hepatic Function
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function
An Open-Label Study to Evaluate the Pharmacokinetics of a Single Oral Dose of 300 mg JNJ-28431754 (Canagliflozin) in Subjects With Various Degrees of Impaired Hepatic Function Compared With Subjects With Normal Hepatic Function
Status: Archived
Clinical Trial Facility
mi
from
Nashville, TN
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function
An Open-Label Study to Evaluate the Pharmacokinetics of a Single Oral Dose of 300 mg JNJ-28431754 (Canagliflozin) in Subjects With Various Degrees of Impaired Hepatic Function Compared With Subjects With Normal Hepatic Function
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Nashville, TN
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Intermountain Medical Center
mi
from
Murray, UT
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Updated: 1/1/1970
Intermountain Medical Center
mi
from
Murray, UT
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Discovery Research
mi
from
West Bend, WI
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Updated: 1/1/1970
Discovery Research
mi
from
West Bend, WI
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation
Status: Archived
Rady Children's Hospital
mi
from
San Diego, CA
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation
Status: Archived
Updated: 1/1/1970
Rady Children's Hospital
mi
from
San Diego, CA
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Denver, CO
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Boston, MA
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Boston, MA
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Lima, OH
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Lima, OH
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Medford, OR
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Medford, OR
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy: A Randomized Prospective Trial
Status: Archived
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy: A Randomized Prospective Trial
Status: Archived
Updated: 1/1/1970
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Wound Edge Changes Following Treatment With Santyl
Evaluation of the Edge of Non-Healing Cutaneous Ulcers Following Debridement With Collagenase Santyl Ointment
Status: Archived
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
mi
from
San Antonio, TX
Wound Edge Changes Following Treatment With Santyl
Evaluation of the Edge of Non-Healing Cutaneous Ulcers Following Debridement With Collagenase Santyl Ointment
Status: Archived
Updated: 1/1/1970
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
mi
from
San Antonio, TX
Correlation of High Resolution Esophageal Manometry With Symptoms
Correlation of High Resolution Esophageal Manometry With Symptoms
Status: Archived
University of Louisville Hospital
mi
from
Louisville, KY
Correlation of High Resolution Esophageal Manometry With Symptoms
Correlation of High Resolution Esophageal Manometry With Symptoms
Status: Archived
Updated: 1/1/1970
University of Louisville Hospital
mi
from
Louisville, KY